Page last updated: 2024-08-21

pyrazines and sch 1473759

pyrazines has been researched along with sch 1473759 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Basso, AD; Esposite, S; Gray, K; Hicklin, DJ; Kerekes, AD; Kirschmeier, P; Lee, S; Liang, L; Liu, M; Monsma, FJ; Ponery, A; Smith, EB; Tagat, JR; Tevar, S; Xiao, Y; Yu, T; Zhang, Y1
Ferraz Nogueira Filho, MA; Figg, WD; Helman, L; McCalla, A; Nguyen, J; Peer, CJ1

Other Studies

2 other study(ies) available for pyrazines and sch 1473759

ArticleYear
SCH 1473759, a novel Aurora inhibitor, demonstrates enhanced anti-tumor activity in combination with taxanes and KSP inhibitors.
    Cancer chemotherapy and pharmacology, 2011, Volume: 68, Issue:4

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Aurora Kinase A; Aurora Kinases; Cell Line, Tumor; Drug Administration Schedule; Female; Humans; Imidazoles; Kinesins; Male; Mice; Mice, Nude; Neoplasms; Protein Serine-Threonine Kinases; Pyrazines; Taxoids; Xenograft Model Antitumor Assays

2011
A simple and rapid UHPLC-MS/MS method for the quantitation of the dual aurora kinase A/B inhibitor SCH-1473759 in murine plasma.
    Journal of pharmaceutical and biomedical analysis, 2017, Jan-05, Volume: 132

    Topics: Administration, Oral; Animals; Aurora Kinase A; Aurora Kinase B; Biological Availability; Chromatography, High Pressure Liquid; Drug Stability; Half-Life; Imidazoles; Linear Models; Liquid-Liquid Extraction; Mice; Plasma; Pyrazines; Quality Control; Reproducibility of Results; Tandem Mass Spectrometry

2017